Home/Filings/4/0000899243-23-010574
4//SEC Filing

Camerlinck Robert 4

Accession 0000899243-23-010574

CIK 0001800682other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 8:39 PM ET

Size

7.7 KB

Accession

0000899243-23-010574

Insider Transaction Report

Form 4
Period: 2023-03-31
Camerlinck Robert
Chief Operating Officer
Transactions
  • Award

    Class A Common Stock

    2023-03-31+70,48623,913,609 total
  • Award

    Stock Option (Right to Buy)

    2023-03-31+147,548147,548 total
    Exercise: $0.91Exp: 2033-03-31Class A Common Stock (147,548 underlying)
Footnotes (2)
  • [F1]These shares represent restricted stock units ("RSUs") granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan. Each unit represents a right to receive one share of the Issuer's Class A Common Stock. The RSUs vest as to 50% of the RSUs on December 31st, 2023 and the remaining 50% of the RSUs vest on December 31st, 2024. The RSUs were granted on March 31, 2023.
  • [F2]The stock option is granted under the Cano Health, Inc. 2021 Stock Option and Incentive Plan and is scheduled to vest over four years, with 25% of the shares underlying the award vesting on March 31, 2024, and 25% of the shares underlying the award vesting at the end of each successive one-year period thereafter. The stock option was granted on March 31, 2023.

Issuer

Cano Health, Inc.

CIK 0001800682

Entity typeother

Related Parties

1
  • filerCIK 0001942114

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 8:39 PM ET
Size
7.7 KB